Journey Medical Statistics

Total Valuation

DERM has a market cap or net worth of $80.13 million. The enterprise value is $70.42 million.

Market Cap	80.13M
Enterprise Value	70.42M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

DERM has 19.93 million shares outstanding. The number of shares has increased by 4.00% in one year.

Shares Outstanding	19.93M
Shares Change (YoY)	+4.00%
Shares Change (QoQ)	-11.13%
Owned by Insiders (%)	29.91%
Owned by Institutions (%)	9.72%
Float	8.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.01
Forward PS	1.35
PB Ratio	3.94
P/FCF Ratio	15.29
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.66, with an EV/FCF ratio of 13.44.

EV / Earnings	n/a
EV / Sales	0.89
EV / EBITDA	36.66
EV / EBIT	n/a
EV / FCF	13.44

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.87.

Current Ratio	1.35
Quick Ratio	1.02
Debt / Equity	0.87
Debt / EBITDA	9.23
Debt / FCF	3.38
Interest Coverage	-1.14

Financial Efficiency

Return on equity (ROE) is -34.10% and return on invested capital (ROIC) is -5.44%.

Return on Equity (ROE)	-34.10%
Return on Assets (ROA)	-5.00%
Return on Capital (ROIC)	-5.44%
Revenue Per Employee	$1.93M
Profits Per Employee	-$93,976
Employee Count	41
Asset Turnover	1.03
Inventory Turnover	2.19

Taxes

In the past 12 months, DERM has paid $221,000 in taxes.

Income Tax	221,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +161.04% in the last 52 weeks. The beta is 0.81, so DERM's price volatility has been lower than the market average.

Beta (1Y)	0.81
52-Week Price Change	+161.04%
50-Day Moving Average	3.93
200-Day Moving Average	3.67
Relative Strength Index (RSI)	51.57
Average Volume (30 Days)	181,816

Short Selling Information

The latest short interest is 148,092, so 0.74% of the outstanding shares have been sold short.

Short Interest	148,092
Short Previous Month	79,160
Short % of Shares Out	0.74%
Short % of Float	1.80%
Short Ratio (days to cover)	0.86

Income Statement

In the last 12 months, DERM had revenue of $79.18 million and -$3.85 million in losses. Loss per share was -$0.21.

Revenue	79.18M
Gross Profit	52.52M
Operating Income	-2.07M
Pretax Income	-3.63M
Net Income	-3.85M
EBITDA	1.92M
EBIT	-1.93M
Loss Per Share	-$0.21

Full Income Statement

Balance Sheet

The company has $27.44 million in cash and $17.73 million in debt, giving a net cash position of $9.71 million or $0.49 per share.

Cash & Cash Equivalents	27.44M
Total Debt	17.73M
Net Cash	9.71M
Net Cash Per Share	$0.49
Equity / Book Value	20.35M
Book Value Per Share	1.02
Working Capital	14.59M

Full Balance Sheet

Cash Flow

Operating Cash Flow	5.24M
Capital Expenditures	n/a
Free Cash Flow	5.24M
FCF Per Share	$0.29

Full Cash Flow Statement

Margins

Gross margin is 66.33%, with operating and profit margins of -2.62% and -4.87%.

Gross Margin	66.33%
Operating Margin	-2.62%
Pretax Margin	-4.59%
Profit Margin	-4.87%
EBITDA Margin	2.43%
EBIT Margin	-2.44%
FCF Margin	6.62%

Dividends & Yields

DERM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.00%
Shareholder Yield	-4.00%
Earnings Yield	-4.81%
FCF Yield	6.54%

Analyst Forecast

The average price target for DERM is $7.25, which is 80.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.25
Price Target Difference	80.35%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DERM has an Altman Z-Score of 0.71 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.71
Piotroski F-Score	6